Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of (177)Lu-octreotate efficacy Meeting Abstract
| Authors: | Bodei, L.; Kidd, M. S.; Singh, A.; van der Zwan, W. A.; Severi, S.; Drozdov, I.; Cwikla, J. B.; Baum, R. P.; Kwekkeboom, D. J.; Paganelli, G.; Krenning, E.; Modlin, I. M. |
| Abstract Title: | Peptide receptor radionuclide therapy (PRRT) transcriptomic signature in blood for prediction of (177)Lu-octreotate efficacy |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 226s |
| Language: | English |
| ACCESSION: | WOS:000442916001677 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.4101 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 4101 -- Source: Wos |
